ENTITY
Edding Genor Group

Edding Genor Group (6998 HK)

46
Analysis
Health Care • China
Edding Genor Group is an integrated specialty biopharmaceutical company focused on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. It discovers, develops, manufactures, and commercializes biopharmaceutical products, primarily through acquiring branded drug assets and licensing patented drugs. The company is headquartered in Shanghai, China, and was founded in 2001.
more
bullish•Ant Group
•13 Sep 2020 09:38

ECM Weekly (13 September 2020) - Ant Group, Joy Spreader, Chindata, Huazhu Secondary, Converge ICT

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. In...

Share
bullish•Edding Genor Group
•19 Jul 2020 13:54

Genor (å˜‰å’Œē”Ÿē‰©) Pre-IPO: Slow R&D Progress in the past but that Might Change

Gencor Biopharmaceutical (hereafter Gencor) is a China based biotech company with a focus on oncology and autoimmune drugs with development...

Logo
600 Views
Share
x